Pharmacology: Heme/Onc Flashcards

(61 cards)

1
Q

Heparin

What lab value do you monitor?

A

Anti-coagulant; binds and enhances anti-thrombin III activity (induces conformational change that allows ATIII to rapidly inhibit thrombin [IIa], Xa, IXa, VIIa)
- Rapid effect
- Does not work on thrombin already bound to fibrin
- Monitor PTT
SE: excessive bleeding, HIT, osteoporosis, hypersensitivity, use low doses to decr risk from thrombosis from reduced levels of ATIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Protamine sulfate

A

Reverses heparin action

- positively charged drug that binds negatively charged heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Enoxaparin

Monitor labs?

A

Anticoagulant; LMWH

  • More Xa effects
  • No labs to monitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lepirudin

A

Anticoagulant; direct thrombin inhibitor

Alternative for anticoaguation in HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bivalirudin

A

Anticoagulant; direct thrombin inhibitor

Alternative for anticoaguation in HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Warfarin (Coumadin)

A

Anticoagulant; inhibits epoxide reductase (gamma-carboxylation of Vit K dependent clotting factors)
- Cyt P450 metabolism
- Long half-life
SEs: bleeding, teratogenic, drug-drug reactions, skin/tissue necrosis! (From pro-thrombotic state when anti-coag PC/PS initially decreases before clotting factors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fondaparinux

A

Synthetic pentasaccharide, selective Factor Xa inhibitor (NOT thrombin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Streptokinase

A

Thrombolytic
Complexes with plasminogen and the resulting complex activates plasminogen to plasmin conversion
- Early MI, early ischemic stroke
SEs: Bleeding! (Don’t use in active bleeding, ICH, recent surgery, bleeding d/o, severe hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Urokinase

A

Thrombolytic

Directly activates plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tPA

A

Thrombolytic

Directly activates plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alteplase

A

Another name for tPA!
Thrombolytic
Directly activates plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anisoylated plasminogen streptokinase activator complex (APSAC)

A

Thrombolytic, already activated complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aminocaproic acid

A

Inhibits fibrinolysis by preventing plasminogen activation

SE: intravascular thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tranexamic acid

A

Inhibits fibrinolysis by preventing plasminogen activation

SE: intravascular thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aspirin

What does the BT, PT, PTT look like?

A

Anti-platelet (low dose), anti-pyretic and analgesic (med dose), anti-inflammatory (high dose)
- Acetylates and irreversibly inhibits COX-1 and -2
- Prevents AA –> TXA2 conversion (which normally mediates plt aggregation) and AA –> PGs
- Increases BT
- No effect on PT/PTT
SEs:
- GI: gastric ulcers, bleeding
- Renal: RF, AIN
- Hyperventilation, tinnitus (CN VIII)
- Reye’s syndrome in kids (rash, encephalitis, fatty liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clopidogrel

A

Anti-platelet

Irreversible blockade of ADP receptors, prevent gpIIb/IIIa expression decr fibrinogen binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ticlopidine

A

Anti-platelet
Irreversible blockade of ADP receptors, prevent gpIIb/IIIa expression decr fibrinogen binding
SE: Neutropenia!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clopidogrel vs. ticlopidine

A

Ticlopidine can cause neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cilostazol

A

PDE III inhibitor (which normally degrade cAMP), increases cAMP and prevents platelet aggregation
Uses: intermittent claudication, coronary vasodilation, prevent stroke/TIA with ASA, ppx angina
SEs: nausea, HA, facial flushing, hypotension,abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dipyridamole

A

PDE III inhibitor (which normally degrade cAMP), increases cAMP and prevents platelet aggregation
Uses: same as cilostazol, also used in pharmacologic stress testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Abiciximab

A

Antiplatelet

Monoclonal antibody against gp IIb/IIIa on activated platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Eptifibaride

A

Antiplatelet

Peptide inhibitor of gp IIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tirofiban

A

Antiplatelet

Non-peptide inhibitor of gp IIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hirudin

A

Direct thrombin inibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Argatroban
Direct thrombin inibitor
26
Methotrexate
Antimetabolite - Folic acid analog, inhibits dihydrofolate reductase leading to decreased formation of dTMP and decreased DNA and protein synthesis - SEs: myelosuppression (leucovorin rescue), macrovesicular fatty liver change, mucositis, teratogenic
27
5-fluorouracil
Antimetabolite - Pyrimidine analog, bioactivated to 5F-dUMP, which covalently complexes folic acid. Complex inhibitis thymidylate synthase - Synergistic with MTX - SEs: myelosuppression, not reversible with leucovorin; photosensitivity
28
6-mercaptopurine
Antimetabolite - Leukemia/lymphoma, but NOT CLL or Hodgkin's - XO metabolism, increased toxicity with allopurinol
29
6-thioguanine
Antimetabolite - ALL - Ok with allopurinol
30
Cytarabine (ara-C)
Antimetabolite | - Pyrimidine analog
31
1. Leucovorin | 2. Allopurinol
1. Myelosuppression by MTX can be rescued via leucovorin, but not with 5-FU 2. 6-MP should not be used with allopurionol (metabolized by XO), but 6-TG is ok
32
What other things can MTX be used for (other than leukemia/lymphoma)?
1. Other cancers: choriocarcinoma, sarcomas (e.g. osteosarcoma) 2. Noncancers: abortion, ectopic pregnancy, RA, psoriasis
33
Dactinomycin | What is is used for?
Antitumor antibiotic - DNA intercalation Childhood tumors!! (Ewing's, Wilms)
34
Doxorubicin
Antitumor antibiotic | - FR generation, non-covalent DNA intercalation leading to DNA breaks and decreased replication
35
Daunorubicin
Antitumor antibiotic | - FR generation, non-covalent DNA intercalation leading to DNA breaks and decreased replication
36
Dexrazoxane
Iron chelating agent | Prevent cardiotoxicity with doxo/daunorubicin therapy
37
Bleomycin
Antitumor antibiotic | - FR generation, non-covalent DNA intercalation leading to DNA breaks and decreased replication
38
Etoposide (VP-16)
Antitumor antibiotic Inhibits topoisomerase II, increases DNA degradation - For small cell carcinoma of lung and prostate, testicular carcinoma SEs: myelosuppresion, alopecia, GI irritation
39
Teniposide
Antitumor antibiotic Inhibits topoisomerase II, increases DNA degradation - For small cell carcinoma of lung and prostate, testicular carcinoma SEs: myelosuppresion, alopecia, GI irritation
40
Cyclophosphamide
Alkylating agent - Covalently cross-link (interstrand) DNA at guanine N-7 - Requires liver bioactivation
41
Ifosfamide
Alkylating agent - Covalently cross-link (interstrand) DNA at guanine N-7 - Requires liver bioactivation
42
Mesna
For ppx of hemorrhagic cystitis by cyclophosphamide and ifosfamide
43
Carmustine
Nitrosourea/alkylating agent - Requires bioactivation - Can cross BBB, use for brain tumors! (GBM) SEs: CNS toxicity--dizziness, ataxia
44
Lomustine
Nitrosourea/alkylating agent - Requires bioactivation - Can cross BBB, use for brain tumors! (GBM) SEs: CNS toxicity--dizziness, ataxia
45
Semustine
Nitrosourea/alkylating agent - Requires bioactivation - Can cross BBB, use for brain tumors! (GBM) SEs: CNS toxicity--dizziness, ataxia
46
Streptozocin
Nitrosourea/alkylating agent - Requires bioactivation - Can cross BBB, use for brain tumors! (GBM) SEs: CNS toxicity--dizziness, ataxia
47
Busulfan
Alkylating agent - CML SEs: pulmonary fibrosis, hyperpigmentation
48
Vincristine
Microtubule inhibitor - Bind tubulin in M phase and inhibit microtubule polymerization - Mitotic spindle cannot form SE: Neurotoxic (areflexia, peripheral neuritis), paralytic ileus
49
Vinblastine
Microtubule inhibitor - Bind tubulin in M phase and inhibit microtubule polymerization - Mitotic spindle cannot form SE: Myelosuppression
50
Paclitaxel
Microtubule inhibitor - Hyperstabilizes polymerized microtubules in M-phase so that mitotic spindle cannot form - Ovarian and breast cancers SEs; Myelosuppression and hypersensitivity
51
Cisplatin
Cross-links DNA | - SEs: Nephrotoxicity, ototoxicity
52
Carboplatin
Cross-links DNA | - SEs: Nephrotoxicity, ototoxicity
53
Amifostine
FR scavenger | Use to prevent nephrotoxicity with -platin chemotherapy
54
Choride diuresis
A method of forced diuresis to enhance excretion of drugs in urine Used to prevent nephrotoxicity with -platin chemotherapy e.g. AlCl.. makes urine more acidic
55
Hydroxyurea
Inhibits ribonucleotide reductase and decreases DNA snythesis in S phase Also increases HbF in SCD - SEs: myelosuppression, GI upset
56
Prednisone
May trigger apoptosis
57
Tamoxifen
SERM
58
Raloxifen
SERM
59
Trastuzumab
aka Herceptin Monoclonal ab against HER-2 (erb-b2), a tyrosine kinase - SE: cardiotoxic
60
Imatinib
aka Gleevec For CML, bcr-abl tyr kinase inhibitor - SE: fluid retention
61
Rituximab
Monoclonal ab against CD20 in B cells | - Used for nHL, RA